Metropolitan Life Insurance Co. NY Has $1,352,000 Position in The Advisory Board Company (NASDAQ:ABCO)

Metropolitan Life Insurance Co. NY continued to hold its stake in The Advisory Board Company (NASDAQ:ABCO) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 28,895 shares of the business services provider’s stock at the end of the first quarter. Metropolitan Life Insurance Co. NY owned approximately 0.07% of The Advisory Board worth $1,352,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in ABCO. Elliott Management Corp purchased a new stake in The Advisory Board during the first quarter worth about $95,047,000. Vista Equity Partners Management LLC boosted its stake in The Advisory Board by 85.4% in the first quarter. Vista Equity Partners Management LLC now owns 184,441 shares of the business services provider’s stock worth $8,632,000 after buying an additional 84,977 shares in the last quarter. State Street Corp boosted its stake in The Advisory Board by 3.1% in the first quarter. State Street Corp now owns 780,730 shares of the business services provider’s stock worth $36,538,000 after buying an additional 23,364 shares in the last quarter. Oppenheimer Asset Management Inc. purchased a new stake in The Advisory Board during the first quarter worth about $249,000. Finally, Schwab Charles Investment Management Inc. boosted its stake in The Advisory Board by 5.5% in the first quarter. Schwab Charles Investment Management Inc. now owns 174,408 shares of the business services provider’s stock worth $8,163,000 after buying an additional 9,039 shares in the last quarter.

The Advisory Board Company (NASDAQ ABCO) opened at 52.05 on Friday. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of 19.77 and a beta of 1.33. The firm has a 50-day moving average price of $54.54 and a 200-day moving average price of $49.71. The Advisory Board Company has a 1-year low of $24.85 and a 1-year high of $59.50.

The Advisory Board (NASDAQ:ABCO) last issued its quarterly earnings results on Tuesday, August 8th. The business services provider reported $0.24 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.32 by $0.08. The Advisory Board had a net margin of 13.65% and a return on equity of 12.69%. The business had revenue of $200.30 million during the quarter, compared to the consensus estimate of $196.16 million. During the same quarter in the previous year, the business posted $0.46 EPS. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, analysts expect that The Advisory Board Company will post $1.91 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Metropolitan Life Insurance Co. NY Has $1,352,000 Position in The Advisory Board Company (NASDAQ:ABCO)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.com-unik.info/2017/08/12/the-advisory-board-company-nasdaqabco-position-maintained-by-metropolitan-life-insurance-co-ny-updated-updated.html.

A number of analysts have recently issued reports on the company. Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $56.00 price objective (up from $53.00) on shares of The Advisory Board in a research report on Thursday. Piper Jaffray Companies set a $51.00 price objective on The Advisory Board and gave the company a “hold” rating in a research report on Thursday. BidaskClub cut The Advisory Board from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. Zacks Investment Research cut The Advisory Board from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 25th. Finally, Robert W. Baird restated an “outperform” rating and set a $65.00 price objective (up from $57.00) on shares of The Advisory Board in a research report on Sunday, July 9th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $51.42.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Institutional Ownership by Quarter for The Advisory Board (NASDAQ:ABCO)

What are top analysts saying about The Advisory Board Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for The Advisory Board Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit